BillionToOne, Inc. (BLLN)
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Sector: Services-Medical Laboratories
Industry: Medical - Diagnostics & Research
BillionToOne, Inc.
No splits on record
Nothing in BLLN's public trading history: no forward or reverse split has affected the share count.
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Revenue | $305.11M | $152.58M | $71.73M |
| YoY Growth | 100.0% | 112.7% | - |
| Cost of Revenue | $96.65M | $71.67M | $54.42M |
| Gross Profit | $208.46M | $80.92M | $17.31M |
| Gross Margin | 68.3% | 53.0% | 24.1% |
| Research and Development | $49.38M | $36.6M | $22.41M |
| Selling, General, and Administrative | $143.05M | $91.47M | $64.39M |
| Other | $0 | $0 | $0 |
| Total Operating Expenses | $192.44M | $128.06M | $86.8M |
| Operating Income (EBIT) | $16.02M | -$47.15M | -$69.5M |
| Operating Margin | 5.3% | -30.9% | -96.9% |
| Interest Expense | $95K | $2.39M | $3.27M |
| Interest Income | $7.75M | $5.82M | $3.46M |
| Other Income (Expense) | -$8.26M | $5.61M | -$13.18M |
| Income Before Tax (EBT) | $7.76M | -$41.54M | -$82.67M |
| Income Tax Expense | $305K | $29K | $9K |
| Net Income | $7.45M | -$41.57M | -$82.68M |
| Net Income Margin | 2.4% | -27.2% | -115.3% |
| Supplementary Data | |||
| EPS | 0.06 | -0.93 | -1.85 |
| Diluted EPS | 0.06 | -0.93 | -1.85 |
| Weighted Average OS | 45.80M | 44.72M | 44.72M |
| EBITDA | $19.76M | -$27.47M | -$72.94M |
| EBITDA Margin | 6.5% | -18.0% | -101.7% |
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Assets | |||
| Current Assets | |||
| Cash and Cash Equivalents | $495.98M | $191.48M | $97.27M |
| Short-Term Investments | $0 | $0 | $0 |
| Cash and Short-Term Investments | $495.98M | $191.48M | $97.27M |
| Accounts Receivable | $41.62M | $24.71M | $9.09M |
| Inventory | $17.55M | $8.73M | $7.2M |
| Other Current Assets | $5.42M | $2.9M | $1.94M |
| Total Current Assets | $560.56M | $227.82M | $115.5M |
| Long-Term Assets | |||
| Property, Plant & Equipment Net | $67.1M | $68.85M | $73.87M |
| Goodwill | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 |
| Other Long-Term Assets | $4.99M | $5.39M | $2.31M |
| Total Long-Term Assets | $72.1M | $74.24M | $76.18M |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $632.65M | $302.06M | $191.68M |
| Liabilities | |||
| Current Liabilities | |||
| Accounts Payable | $7.18M | $4.3M | $3.21M |
| Short-Term Debt | $5.6M | $6.22M | $53.74M |
| Current Income Tax Payable | $0 | $0 | $0 |
| Current Unearned Revenue | $2.19M | $2.81M | $3.02M |
| Other Current Liabilities | $20.44M | $6.64M | $4.26M |
| Total Current Liabilities | $47.96M | $28.39M | $66.8M |
| Long-Term Liabilities | |||
| Long-Term Debt | $57.23M | $51.48M | $35M |
| Long-Term Unearned Revenue | $1.29M | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $2.76M | $1.8M |
| Total Long-Term Liabilities | $104.59M | $105.92M | $94.4M |
| Other Liabilities | $0 | $0 | $0 |
| Total Liabilities | $152.55M | $134.31M | $161.2M |
| Stockholders' Equity | |||
| Preferred Stock | $0 | $419.41M | $249.53M |
| Common Stock | $0 | $0 | $0 |
| Retained Earnings | -$274.75M | -$282.2M | -$240.63M |
| Comprehensive Income & Other | $0 | $0 | $0 |
| Other Stockholders' Equity | $754.85M | $449.95M | $271.11M |
| Total Equity | $480.11M | $167.75M | $30.47M |
| Minority Interest | $0 | $0 | $0 |
| Total Liabilities and Equity | $632.65M | $302.06M | $191.68M |
| Supplementary Data | |||
| Total Debt | $108.89M | $109.38M | $146.35M |
| Net Debt | -$387.08M | -$82.1M | $49.08M |
| Period | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Currency | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
| Operating Activities | |||
| Net Income | $2.92M | -$41.57M | -$82.68M |
| Depreciation & Amortization | $11.91M | $11.69M | $6.46M |
| Deferred Income Tax | $0 | $0 | $0 |
| Stock-Based Compensation | $15.91M | $8.36M | $4.85M |
| Changes in Working Capital: | |||
| Accounts Receivable | -$16.91M | -$15.62M | -$2.59M |
| Inventory | -$8.81M | -$1.53M | -$1.41M |
| Accounts Payable | $1.77M | $877K | $151K |
| Other Working Capital | $1.89M | -$489K | $7.64M |
| Total Working Capital Change | -$22.05M | -$16.77M | $3.79M |
| Other Non-Cash Items | $15.91M | -$3.09M | $13.9M |
| Net Cash from Operating | $24.59M | -$41.38M | -$53.67M |
| Investing Activities | |||
| Capital Expenditures | -$8.92M | -$5.4M | -$6.17M |
| Acquisitions | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $90M |
| Other Investing Activities | $0 | -$31K | -$988K |
| Net Cash from Investing | -$8.92M | -$5.43M | $82.84M |
| Financing Activities | |||
| Debt Repaid | $1.73M | -$10.48M | -$12.96M |
| Common Stock Issuance | $290.55M | $131.08M | $444K |
| Common Stock Repurchases | $0 | -$546K | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 |
| Net Cash from Financing | $288.82M | $141.02M | $13.4M |
| Forex Effect | $0 | $0 | $54.7M |
| Net Change in Cash | $304.5M | $94.21M | $97.27M |
| Supplementary Data | |||
| Operating Cash Flow | $24.59M | -$41.38M | -$53.67M |
| Capital Expenditure | -$8.88M | -$5.4M | -$6.17M |
| Free Cash Flow | $15.71M | -$46.78M | -$59.85M |
| Cash at Beginning | $191.48M | $97.27M | $0 |
| Cash at End | $495.98M | $191.48M | $97.27M |